Etoposide

Two common platinum-based chemotherapies that had been in short supply for most of the past year are much more widely available this summer, according to results of a new National Comprehensive Cancer Network survey.

Childhood cancer survivors in France are less likely to develop obesity compared with the country’s general population, according to a study published in Obesity.

Glasgow prognostic score appeared associated with survival among patients with small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide, according to study results.

CHICAGO — Adding tiragolumab, an anti-TIGIT agent, to atezolizumab and carboplatin plus etoposide did not provide more benefit compared with atezolizumab and carboplatin plus etoposide alone, according to findings from SKYSCRAPER-02 trial.

In this video, Vivek Subbiah, MD, associate professor at The University of Texas MD Anderson Cancer Center, discussed results from KEYNOTE-604.

Patients with resectable stage IIIA non-small cell lung cancer treated with concurrent pembrolizumab plus neoadjuvant concurrent chemoradiation had high pathologic complete response rate at resection, however safety is a concern, according to data presented at the virtual ASCO Annual Meeting.

De-escalation of treatment after two cycles of chemotherapy and a negative PET scan appeared safe and feasible among a cohort of men with low-volume metastatic seminoma, according to results of a phase 2 trial presented at Genitourinary Cancers Symposium.

BARCELONA — The addition of durvalumab to platinum-etoposide chemotherapy significantly extended OS among patients with extensive-stage small cell lung cancer, according to results of the CASPIAN study presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.